Project Grant R21DA065818
Award Date 6/1/26
Completion Date 5/30/28
Dollars Obligated $479K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $1.62M Project Grant on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the role of striatal molecular rhythms in sleep disruption and opioid use disorder (OUD). The research will be conducted through April 30, 2030, and addresses the critical gap in understanding how molecular rhythm disruptions in the brain's reward and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital (MGH) a Project Grant totaling $476,808 under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop precision risk modeling tools for reducing opioid overdose deaths among individuals experiencing homelessness. The award, dated May 15, 2026, with completion targeted for April 30, 2028, funds research that will derive and validate prediction models for opioid overdose...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded the University of Massachusetts Lowell a $1,009,623 Project Grant (CFDA 93.279, Drug Use and Addiction Research Programs) effective June 1, 2026, through May 31, 2028. The award supports discovery and development of novel, non-opioid analgesics derived from marine microbial natural products to address chronic pain, identified as the nation's leading public health crisis affecting over 25...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $1.74 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 15, 2025, with completion targeted for March 31, 2030. This award supports research focused on the discovery and functional characterization of long non-coding RNAs (lncRNAs) in opioid use disorder (OUD) within the context of HIV at single-cell resolution. The...
- Federal Project Grant Award Summary Boston University Medical Campus received a $109,076 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded January 9, 2026, with completion targeted for July 31, 2029. The grant supports basic neuroscience research investigating the role of G alpha Z (GAZ) protein in mediating behavioral responses to opioids. The research aims to elucidate how GAZ signaling in specific brain...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $906,124 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through May 31, 2030. The award supports basic neuroscience research investigating the cellular mechanisms underlying opioid tolerance—a critical clinical problem in pain management where prolonged opioid use requires increasing dosages...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital a Project Grant of $451,670 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support the final preclinical evaluation of a safe and accessible positron emission tomography (PET) neuroimaging probe designated 18F-fluorocarfentanil (18F-FCFN). This project addresses the urgent public health need to better understand the neurobiology of opioid...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $386,500 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 15, 2025 through August 31, 2027. This R21 exploratory grant funds neuroscience research investigating the relationship between fentanyl overdose (OD), anhedonia (loss of pleasure/reward motivation), and relapse risk in opioid use disorder (OUD). The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $3.2 million Project Grant to the University of Massachusetts on September 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to establish the Massachusetts Justice Community Opioid Innovation Network Phase II (MASS JCOIN II) Clinical Research Hub. This five-year research initiative, concluding May 31, 2030, builds upon Phase I findings demonstrating that only 50% of individuals receiving...
- Federal Grant Award Summary Massachusetts General Hospital received a $769,268 Project Grant from the National Institute on Drug Abuse (Drug Use and Addiction Research Programs, CFDA 93.279) awarded March 1, 2026, with completion scheduled for December 31, 2029. The award funds a research study examining the ethical, clinical, and implementation challenges associated with using genomic tests based on polygenic risk scores (PRS) to identify individuals at increased genetic risk for opioid use...